Lee Min Ho, Lee Sun-Ho, Kim Eun-Sang, Eoh Whan, Chung Sung-Soo, Lee Chong-Suh
Department of Neurosurgery, Spine Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Orthopedic Surgery, Spine Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Korean Neurosurg Soc. 2015 Nov;58(5):448-53. doi: 10.3340/jkns.2015.58.5.448. Epub 2015 Nov 30.
Recently, the survival of patients with hepatocellular carcinoma (HCC) has been prolonged with improvements in various diagnostic tools and medical treatment modalities. Consequently, spine metastases from HCC are being diagnosed more frequently. The accurate prediction of prognosis plays a critical role in determining a patient's treatment plan, including surgery for patients with spinal metastases of HCC. We investigated the clinical features, surgical outcomes, and prognostic factors of HCC presenting with spine metastases, in patients who underwent surgery.
A retrospective review was conducted on 33 HCC patients who underwent 36 operations (three patients underwent surgical treatment twice) from February 2006 to December 2013. The median age of the patients was 56 years old (range, 28 to 71; male : female=30 : 3).
Overall survival was not correlated with age, sex, level of metastases, preoperative Child-Pugh classification, preoperative ambulatory function, preoperative radiotherapy, type of operation, administration of Sorafenib, or the Tokuhashi scoring system. Only the Tomita scoring system was shown to be an independent prognostic factor for overall survival. Comparing the Child-Pugh classification and ambulatory ability, there were no statistically differences between patients pre- and post-operatively.
The Tomita scoring system represents a practicable and highly predictive prognostic tool. Even though surgical intervention may not restore ambulatory function, it should be considered to prevent deterioration of the patient's overall condition. Additionally, aggressive management may be needed if there is any ambulatory ability remaining.
近年来,随着各种诊断工具和医疗治疗方式的改进,肝细胞癌(HCC)患者的生存期得以延长。因此,HCC脊柱转移的诊断也越来越频繁。准确预测预后对于确定患者的治疗方案起着关键作用,包括对HCC脊柱转移患者的手术治疗。我们调查了接受手术的HCC脊柱转移患者的临床特征、手术结果和预后因素。
对2006年2月至2013年12月期间33例接受36次手术(3例患者接受了两次手术治疗)的HCC患者进行回顾性研究。患者的中位年龄为56岁(范围28至71岁;男∶女 = 30∶3)。
总生存期与年龄、性别、转移部位、术前Child-Pugh分级、术前活动功能、术前放疗、手术类型、索拉非尼的使用或Tokuhashi评分系统均无相关性。仅Tomita评分系统被证明是总生存期的独立预后因素。比较Child-Pugh分级和活动能力,患者术前和术后无统计学差异。
Tomita评分系统是一种实用且预测性很强的预后工具。尽管手术干预可能无法恢复活动功能,但仍应考虑进行手术以防止患者整体状况恶化。此外,如果患者仍有任何活动能力,可能需要积极治疗。